168 related articles for article (PubMed ID: 27617998)
1. NO-Releasing Enmein-Type Diterpenoid Derivatives with Selective Antiproliferative Activity and Effects on Apoptosis-Related Proteins.
Li D; Hu X; Han T; Liao J; Xiao W; Xu S; Li Z; Wang Z; Hua H; Xu J
Molecules; 2016 Sep; 21(9):. PubMed ID: 27617998
[TBL] [Abstract][Full Text] [Related]
2. Synthesis, Cytotoxicity and Antimicrobial Activity of New Enmein-type Kauranoid Diterpenoid Derivatives.
Li D; Han T; Hu X; Tian K; Xu S; Zhou T; Cheng K; Li Z; Hua H; Xu J
Anticancer Agents Med Chem; 2017; 17(12):1679-1688. PubMed ID: 28403782
[TBL] [Abstract][Full Text] [Related]
3. Novel nitric oxide-releasing spirolactone-type diterpenoid derivatives with in vitro synergistic anticancer activity as apoptosis inducer.
Li D; Han T; Tian K; Tang S; Xu S; Hu X; Wang L; Li Z; Hua H; Xu J
Bioorg Med Chem Lett; 2016 Sep; 26(17):4191-6. PubMed ID: 27491707
[TBL] [Abstract][Full Text] [Related]
4. Novel anticancer oridonin derivatives possessing a diazen-1-ium-1,2-diolate nitric oxide donor moiety: Design, synthesis, biological evaluation and nitric oxide release studies.
Xu S; Wang G; Lin Y; Zhang Y; Pei L; Yao H; Hu M; Qiu Y; Huang Z; Zhang Y; Xu J
Bioorg Med Chem Lett; 2016 Jun; 26(12):2795-2800. PubMed ID: 27158140
[TBL] [Abstract][Full Text] [Related]
5. Synthesis, Biological Activity, and Apoptotic Properties of NO-Donor/Enmein-Type ent-Kauranoid Hybrids.
Li D; Hu X; Han T; Xu S; Zhou T; Wang Z; Cheng K; Li Z; Hua H; Xiao W; Xu J
Int J Mol Sci; 2016 May; 17(6):. PubMed ID: 27231893
[TBL] [Abstract][Full Text] [Related]
6. Novel enmein-type diterpenoid hybrids coupled with nitrogen mustards: Synthesis of promising candidates for anticancer therapeutics.
Gao X; Li J; Wang M; Xu S; Liu W; Zang L; Li Z; Hua H; Xu J; Li D
Eur J Med Chem; 2018 Feb; 146():588-598. PubMed ID: 29407983
[TBL] [Abstract][Full Text] [Related]
7. Hydrogen sulfide releasing enmein-type diterpenoid derivatives as apoptosis inducers through mitochondria-related pathways.
Xu F; Gao X; Li H; Xu S; Li X; Hu X; Li Z; Xu J; Hua H; Li D
Bioorg Chem; 2019 Feb; 82():192-203. PubMed ID: 30326401
[TBL] [Abstract][Full Text] [Related]
8. Effective enmein-type mimics of clinical candidate HAO472: Design, synthesis and biological evaluation.
Hu X; Bai Z; Qiao J; Li H; Xu S; Wang X; Xu Y; Xu J; Hua H; Li D
Eur J Med Chem; 2019 Jun; 171():169-179. PubMed ID: 30921757
[TBL] [Abstract][Full Text] [Related]
9. Lasiokaurin derivatives: synthesis, antimicrobial and antitumor biological evaluation, and apoptosis-inducing effects.
Li DH; Hu P; Xu ST; Fang CY; Tang S; Wang XY; Sun XY; Li H; Xu Y; Gu XK; Xu JY
Arch Pharm Res; 2017 Jul; 40(7):796-806. PubMed ID: 28110416
[TBL] [Abstract][Full Text] [Related]
10. Library construction and biological evaluation of enmein-type diterpenoid analogues as potential anticancer agents.
Li D; Xu S; Cai H; Pei L; Wang L; Wu X; Yao H; Jiang J; Sun Y; Xu J
ChemMedChem; 2013 May; 8(5):812-8. PubMed ID: 23520191
[TBL] [Abstract][Full Text] [Related]
11. Enmein-type diterpenoid analogs from natural kaurene-type oridonin: Synthesis and their antitumor biological evaluation.
Li D; Xu S; Cai H; Pei L; Zhang H; Wang L; Yao H; Wu X; Jiang J; Sun Y; Xu J
Eur J Med Chem; 2013 Jun; 64():215-21. PubMed ID: 23644204
[TBL] [Abstract][Full Text] [Related]
12. Synthesis of spirolactone-type diterpenoid derivatives from kaurene-type oridonin with improved antiproliferative effects and their apoptosis-inducing activity in human hepatoma Bel-7402 cells.
Li D; Cai H; Jiang B; Liu G; Wang Y; Wang L; Yao H; Wu X; Sun Y; Xu J
Eur J Med Chem; 2013 Jan; 59():322-8. PubMed ID: 23274570
[TBL] [Abstract][Full Text] [Related]
13. The conversion of oridonin to spirolactone-type or enmein-type diterpenoid: synthesis and biological evaluation of ent-6,7-seco-oridonin derivatives as novel potential anticancer agents.
Wang L; Li D; Xu S; Cai H; Yao H; Zhang Y; Jiang J; Xu J
Eur J Med Chem; 2012 Jun; 52():242-50. PubMed ID: 22483090
[TBL] [Abstract][Full Text] [Related]
14. Hydrogen sulfide donating ent-kaurane and spirolactone-type 6,7-seco-ent-kaurane derivatives: Design, synthesis and antiproliferative properties.
Li H; Gao X; Huang X; Wang X; Xu S; Uchita T; Gao M; Xu J; Hua H; Li D
Eur J Med Chem; 2019 Sep; 178():446-457. PubMed ID: 31202992
[TBL] [Abstract][Full Text] [Related]
15. Hydrogen sulfide releasing oridonin derivatives induce apoptosis through extrinsic and intrinsic pathways.
Li H; Mu J; Sun J; Xu S; Liu W; Xu F; Li Z; Xu J; Hua H; Li D
Eur J Med Chem; 2020 Feb; 187():111978. PubMed ID: 31877536
[TBL] [Abstract][Full Text] [Related]
16. Design, synthesis and apoptosis-related antiproliferative activities of chelidonine derivatives.
Huang X; Cheng K; Liu L; Hu X; Gao X; Li H; Xu F; Li Z; Hua H; Li D
Bioorg Med Chem Lett; 2020 Feb; 30(4):126913. PubMed ID: 31883693
[TBL] [Abstract][Full Text] [Related]
17. Synthesis of scutellarein derivatives with antiproliferative activity and selectivity through the intrinsic pathway.
Han T; Wang Y; Wang M; Li X; Cheng K; Gao X; Li Z; Bai J; Hua H; Li D
Eur J Med Chem; 2018 Oct; 158():493-501. PubMed ID: 30243153
[TBL] [Abstract][Full Text] [Related]
18. Antiproliferative activity and apoptosis inducing effects of nitric oxide donating derivatives of evodiamine.
Zhao N; Tian KT; Cheng KG; Han T; Hu X; Li DH; Li ZL; Hua HM
Bioorg Med Chem; 2016 Jul; 24(13):2971-2978. PubMed ID: 27178387
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and biological evaluation of novel furozan-based nitric oxide-releasing derivatives of oridonin as potential anti-tumor agents.
Li D; Wang L; Cai H; Zhang Y; Xu J
Molecules; 2012 Jun; 17(6):7556-68. PubMed ID: 22710829
[TBL] [Abstract][Full Text] [Related]
20. Antitumor and Antibacterial Derivatives of Oridonin: A Main Composition of Dong-Ling-Cao.
Li D; Han T; Xu S; Zhou T; Tian K; Hu X; Cheng K; Li Z; Hua H; Xu J
Molecules; 2016 Apr; 21(5):. PubMed ID: 27144553
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
